Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease (Background paper)
Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease (Background paper)
Details
- OL Work ID
- OL18824310W
Subjects
United StatesGaucher's diseaseTreatmentPharmaceutical policyOrphan drugsGaucher diseaseDrug therapyGlucosylceramidaseTherapeutic useOrphan Drug ProductionEconomics